<?xml version="1.0" encoding="UTF-8"?>
<p>In 2019, Cao and Woodrow [
 <xref rid="B124-pharmaceutics-12-00171" ref-type="bibr">124</xref>] reviewed the nanotechnology solutions used to eradicate HIV reservoirs and also the gene delivery and immunotherapy nanocarriers used in cancer with potential in HIV treatment. In 
 <xref ref-type="sec" rid="sec4-pharmaceutics-12-00171">Section 4</xref>. Nanocarriers for eradicating HIV reservoirs‚Äù the authors focused mainly on nanocarriers incorporating combination therapeutics developed in order to boost drug effectiveness and minimize toxicity. Several examples are presented in 
 <xref rid="pharmaceutics-12-00171-t002" ref-type="table">Table 2</xref> and described in 
 <xref ref-type="sec" rid="sec5-pharmaceutics-12-00171">Section 5</xref>.
</p>
